Johnson & Johnson (JNJ) Tops Q4 EPS by 3c; Guides FY12 Below the Street
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $270.67 +1.23%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.13, $0.03 better than the analyst estimate of $1.10. Revenue for the quarter came in at $16.255 billion versus the consensus estimate of $16.29 billion.
Johnson & Johnson sees FY2012 EPS of $5.05-$5.15, versus the consensus of $5.21.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Johnson & Johnson sees FY2012 EPS of $5.05-$5.15, versus the consensus of $5.21.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Is the global equity rally broadening? UBS weighs in
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
